相关实验视频

Updated: Jan 8, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

在杜恩肌肉发育不良症的其他创新疗法

¹Evolution of Neuromuscular Diseases - Innovative Concepts and Practice (END-ICAP) U1179, Université Paris-Saclay, Université de Versailles Saint-Quentin-en-Yvelines, Inserm, 78000 Versailles, France; Pediatric Department, Raymond Poincaré Hospital, Université Paris-Saclay, Université de Versailles Saint-Quentin-en-Yvelines, Assistance Publique Hôpitaux de Paris, 92380 Garches, France.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

|December 14, 2025

概括

新的杜恩肌肉发育不良 (DMD) 治疗重点是基因纠正,管理副作用和肌肉再生. 目前的研究探讨了对DMD患者的缩蛋白恢复,先进药物和细胞治疗.

科学领域:

生物医学研究的研究.
神经肌肉疾病神经肌肉疾病
基因治疗是一种基因疗法.

背景情况:

杜申肌肉发育不良 (DMD) 是一种严重的遗传性疾病.
肌肉消耗和退化是DMD的特征.
对DMD的有效治疗方法有限.

研究的目的:

审查杜氏肌肉发育不良症的新兴治疗策略.
讨论目前用于DMD治疗的临床试验概念.
为突出基因,药物和细胞治疗DMD的进步.

主要方法:

对最近的DMD治疗策略的审查.
在临床试验中讨论三个关键的治疗概念.
专注于消毒素恢复,下一代药物和细胞疗法.

主要成果:

对于DMD,正在研究多种治疗途径.
策略针对遗传缺陷,二次病理和肌肉再生.
临床试验正在评估双氨酸恢复,新型药物和基于细胞的方法.

结论:

在开发新的DMD疗法方面取得了重大进展.
恢复营养不良蛋白,先进的药理学和细胞疗法显示出有希望的结果.
这些策略有可能改善杜氏肌肉发育不良症患者的治疗结果.

关键词:

杜申尼肌肉发育不良症杜申尼肌肉发育不良症迪斯特罗芬 (Dystrophin) 是一种消极蛋白质.创新创新创新创新创新创新创新治疗疗法治疗疗法

更多相关视频

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

相关概念视频

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...